Key Resolutions and Voting Process

The postal ballot contained two special resolutions for which shareholder approval was sought through remote e-voting only:

1. Approval for Purchase of Land and Building from Nueclear Healthcare Limited: A special resolution pursuant to Regulation 24(6) of SEBI LODR.

2. Approval for sale or divestment of Company's entire shareholding in Nueclear Healthcare Limited (NHL): A special resolution requiring an additional approval by a majority of the public shareholders as per Regulation 37A of SEBI LODR. The disclosed buyer is Trovera Healthcare Private Limited.

The remote e-voting period commenced on Wednesday, September 30, 2026 (09:00 A.M. IST) and ended on Thursday, October 29, 2026 (05:00 P.M. IST). The cut-off date for determining shareholder eligibility to vote was Friday, September 25, 2026. The total number of shareholders on this record date was 76,689.

Central Depository Services (India) Limited (CDSL) was the remote e-voting service provider. MUFG Intime India Private Limited is the Company's Registrar and Share Transfer Agent (RTA).

Detailed Voting Results

Resolution 1: Purchase of Land and Building from NHL

  • The resolution was passed as a special resolution.
  • Total Votes Polled: 132,320,192 shares (83.1338% of outstanding shares).
  • Votes in Favour: 132,319,807 shares (99.9997% of votes polled).
  • Votes Against: 385 shares (0.0003% of votes polled).
  • The scrutinizer's report confirms 409 members voted in favour (132,319,807 shares) and 10 members voted against (385 shares). There were no invalid or abstained votes.

Resolution 2: Divestment of Entire Shareholding in NHL

  • The resolution was passed as a special resolution by all shareholders and also received the requisite majority from public shareholders as per Regulation 37A.
  • Total Votes Polled: 132,320,192 shares (83.1338% of outstanding shares).
  • Votes in Favour (All Shareholders): 122,950,189 shares (92.9187% of votes polled).
  • Votes Against (All Shareholders): 9,370,003 shares (7.0813% of votes polled).
  • Votes in Favour (Public Shareholders only - for Reg. 37A): 41,750,189 shares (81.67% of public votes polled).
  • Votes Against (Public Shareholders only - for Reg. 37A): 9,370,003 shares (18.33% of public votes polled).
  • The scrutinizer's report confirms 394 members voted in favour (122,950,189 shares) and 25 members voted against (9,370,003 shares) among all shareholders. From the public shareholder subset, 393 members voted in favour (41,750,189 shares) and 25 members voted against (9,370,003 shares). There were no invalid or abstained votes.

Scrutinizer's Report

Nupur Gadekar, Partner at M/s. Mehta & Mehta, Company Secretaries, was appointed as the Scrutinizer. The report, dated October 29, 2026, confirms the voting was conducted fairly and transparently in accordance with the Companies Act, 2013, its associated rules, and SEBI regulations. The report validates the results mentioned above.

Effective Date and Compliance

The resolutions are deemed to have been passed on the last date of the remote e-voting period, which is Thursday, October 29, 2026.

This information has been disclosed to the stock exchanges and is also available on the company's website (www.thyrocare.com) and the CDSL e-voting website (https://www.evotingindia.com/).

Financial Impact

Financial impact not quantified in the disclosure.